Document:

<PAGE>

                                                                    EXHIBIT 4.14

NEITHER THESE SECURITIES NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE
EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR
THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES
ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS THEREUNDER AND IN
COMPLIANCE WITH APPLICABLE STATE SECURITIES OR BLUE SKY LAWS.

                                 STEMCELLS, INC.

                                CALLABLE WARRANT

Warrant No. CW-3  Dated: June 21, 2001

                  STEMCELLS, INC., a Delaware corporation (the "Company"),
hereby certifies that, for value received, MILLENNIUM PARTNERS, L.P., or its
registered assigns ("Holder"), is entitled, subject to the terms set forth
below, to purchase from the Company a total of 50,352 shares of common stock,
$.01 par value per share (the "Common Stock"), of the Company (each such share,
a "Warrant Share" and all such shares, the "Warrant Shares") at an exercise
price equal to $4.7664 per share (as adjusted from time to time as provided in
Section 9, the "Exercise Price"), at any time and from time to time from and
after the date hereof and through and including June 21, 2006 (the "Expiration
Date"), and subject to the following terms and conditions:

                  1. REGISTRATION OF WARRANT. The Company shall register this
Warrant, upon records to be maintained by the Company for that purpose (the
"Warrant Register"), in the name of the record Holder hereof from time to time.
The Company may deem and treat the registered Holder of this Warrant as the
absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, and the Company shall not be affected
by notice to the contrary.

                  2. REGISTRATION OF TRANSFERS AND EXCHANGES.

                           (a) The Company shall register the transfer of any
portion of this Warrant in the Warrant Register, upon surrender of this Warrant,
with the Form of Assignment attached hereto duly completed and signed, to the
Transfer Agent or to the Company at the office specified in or pursuant to
Section 3(b). Upon any such registration or transfer, a new warrant to purchase
Common Stock, in substantially the form of this Warrant (any such new warrant, a
"New Warrant"), evidencing the portion of this Warrant so transferred shall be
issued to the transferee and a New Warrant evidencing the remaining portion of
this Warrant not so transferred, if any, shall be issued to the transferring
Holder. The acceptance of the New
<PAGE>

Warrant by the transferee thereof shall be deemed the acceptance of such
transferee of all of the rights and obligations of a holder of a Warrant.

                           (b) This Warrant is exchangeable, upon the surrender
hereof by the Holder to the office of the Company specified in or pursuant to
Section 3(b) for one or more New Warrants, evidencing in the aggregate the right
to purchase the number of Warrant Shares which may then be purchased hereunder.
Any such New Warrant will be dated the date of such exchange.

                  3. DURATION, EXERCISE AND REDEMPTION OF WARRANTS.

                           (a) This Warrant shall be exercisable by the
registered Holder on any business day before 5:00 P.M., New York City time, at
any time and from time to time on or after the date hereof to and including the
Expiration Date. At 5:00 P.M., New York City time on the Expiration Date, the
portion of this Warrant not exercised prior thereto shall be and become void and
of no value.

                           (b) Subject to Sections 2(b), 5 and 10, upon
surrender of this Warrant, with the Form of Election to Purchase attached hereto
duly completed and signed, to the Company at its address for notice set forth in
Section 13 and upon payment of the Exercise Price multiplied by the number of
Warrant Shares that the Holder intends to purchase hereunder, in the manner
provided hereunder, all as specified by the Holder in the Form of Election to
Purchase, the Company shall promptly (but in no event later than 3 business days
after the Date of Exercise (as defined herein)) issue or cause to be issued and
cause to be delivered to or upon the written order of the Holder and in such
name or names as the Holder may designate, a certificate for the Warrant Shares
issuable upon such exercise, free of restrictive legends except (i) either in
the event that a registration statement covering the resale of the Warrant
Shares and naming the Holder as a selling stockholder thereunder is not then
effective or the Warrant Shares are not freely transferable without volume
restrictions pursuant to Rule 144(k) promulgated under the Securities Act of
1933, as amended (the "Securities Act"), or (ii) if this Warrant shall have been
issued pursuant to a written agreement between the original Holder and the
Company, as required by such agreement. Any person so designated by the Holder
to receive Warrant Shares shall be deemed to have become holder of record of
such Warrant Shares as of the Date of Exercise of this Warrant.

                           A "Date of Exercise" means the date on which the
Company shall have received (i) this Warrant (or any New Warrant, as
applicable), with the Form of Election to Purchase attached hereto (or attached
to such New Warrant) appropriately completed and duly signed, and (ii) payment
of the Exercise Price for the number of Warrant Shares so indicated by the
holder hereof to be purchased.

                           (c) This Warrant shall be exercisable, either in its
entirety or, from time to time, for a portion of the number of Warrant Shares.
If less than all of the Warrant Shares which may be purchased under this Warrant
are exercised at any time, the Company shall issue or cause to be issued, at its
expense, a New Warrant evidencing the right to purchase the remaining number of
Warrant Shares for which no exercise has been evidenced by this Warrant.

                                       2
<PAGE>

                  (d) In lieu of delivering physical certificates representing
the Warrant Shares issuable upon conversion of this Warrant, provided the
Company's transfer agent is participating in the Depository Trust Company
("DTC") Fast Automated Securities Transfer ("FAST") program, upon request of the
Holder, the Company shall use its best efforts to cause its transfer agent to
electronically transmit the Warrant Shares issuable upon exercise to the Holder,
by crediting the account of the Holder's prime broker with DTC through its
Deposit Withdrawal Agent Commission ("DWAC") system. The time periods for
delivery described above shall apply to the electronic transmittals through the
DWAC system. The Company agrees to coordinate with DTC to accomplish this
objective.

                  (e) Commencing at any time after the date of the issuance of
this Warrant, the Company shall have the right, upon fifteen (15) days notice to
the Holder, to cancel this Warrant in full effective on such 15th day (the
"Cancellation Date"). The Holder may exercise this Warrant at any time prior to
the Cancellation Date. On the Cancellation Date, the Company shall pay in full
and complete satisfaction of its obligations under the remaining portion of this
Warrant to the Holder an amount in cash equal to (i) the number of shares of
Common Stock then issuable hereunder multiplied by (ii) $7.944, as such number
shall be appropriately adjusted for stock splits, recapitalizations and similar
events minus the applicable Exercise Price as of the Cancellation Date, and the
Holder shall surrender this Warrant to the Company for cancellation.

                 4. REGISTRATION RIGHTS. This Warrant and the Holder hereof are
entitled to the benefits of, and subject to the terms and condition of and
obligations under, that certain Registration Rights Agreement dated the date
hereof between the Company and the original Holder (the "Registration Rights
Agreement").

                  5. Intentionally left blank.

                  6. PAYMENT OF TAXES. The Company will pay all documentary
stamp taxes attributable to the issuance of Warrant Shares upon the exercise of
this Warrant; provided, however, that the Company shall not be required to pay
any tax which may be payable in respect of any transfer involved in the
registration of any certificates for Warrant Shares or Warrants in a name other
than that of the Holder. The Holder shall be responsible for all other tax
liability that may arise as a result of holding or transferring this Warrant or
receiving Warrant Shares upon exercise hereof.

                  7. REPLACEMENT OF WARRANT. If this Warrant is mutilated, lost,
stolen or destroyed, the Company shall issue or cause to be issued in exchange
and substitution for and upon cancellation hereof, or in lieu of and
substitution for this Warrant, a New Warrant, but only upon receipt of evidence
reasonably satisfactory to the Company of such loss, theft or destruction and
indemnity, if requested, satisfactory to it. Applicants for a New Warrant under
such circumstances shall also comply with such other reasonable regulations and
procedures and pay such other reasonable charges as the Company may prescribe.

                  8. RESERVATION OF WARRANT SHARES. The Company covenants that
it will at all times reserve and keep available out of the aggregate of its
authorized but unissued Common Stock, solely for the purpose of enabling it to
issue Warrant Shares upon exercise of this Warrant as herein provided, the
number of Warrant Shares which are then issuable and deliverable upon

                                       3
<PAGE>

the exercise of this entire Warrant, free from preemptive rights or any other
actual contingent purchase rights of persons other than the Holder (taking into
account the adjustments and restrictions of Section 9). The Company covenants
that all Warrant Shares that shall be so issuable and deliverable shall, upon
issuance and the payment of the applicable Exercise Price in accordance with the
terms hereof, be duly and validly authorized, issued and fully paid and
nonassessable.

                  9. CERTAIN ADJUSTMENTS. The Exercise Price and number of
Warrant Shares issuable upon exercise of this Warrant are subject to adjustment
from time to time as set forth in this Section. Upon each such adjustment of the
Exercise Price pursuant to this Section, the Holder shall thereafter prior to
the Expiration Date be entitled to purchase, at the Exercise Price resulting
from such adjustment, the number of Warrant Shares obtained by multiplying the
Exercise Price in effect immediately prior to such adjustment by the number of
Warrant Shares issuable upon exercise of this Warrant immediately prior to such
adjustment and dividing the product thereof by the Exercise Price resulting from
such adjustment.

                           (a) If the Company, at any time while this Warrant is
outstanding, (i) shall pay a stock dividend or otherwise make a distribution or
distributions on shares of its Common Stock or on any other class of capital
stock payable in shares of Common Stock (except dividends or distributions paid
on preferred or other senior stock), (ii) subdivide outstanding shares of Common
Stock into a larger number of shares, or (iii) combine outstanding shares of
Common Stock into a smaller number of shares, the Exercise Price shall be
multiplied by a fraction of which the numerator shall be the number of shares of
Common Stock (excluding treasury shares, if any) outstanding before such event
and of which the denominator shall be the number of shares of Common Stock
(excluding treasury shares, if any) outstanding after such event. Any adjustment
made pursuant to this Section shall become effective immediately after the
record date for the determination of stockholders entitled to receive such
dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision or combination, and shall apply to
successive subdivisions and combinations.

                           (b) In case of any reclassification of the Common
Stock or any compulsory share exchange pursuant to which the Common Stock is
converted into other securities, cash or property, then the Holder shall have
the right thereafter to exercise this Warrant only into the shares of stock and
other securities and property receivable upon or deemed to be held by holders of
Common Stock following such reclassification or share exchange, and the Holder
shall be entitled upon such event to receive such amount of securities or
property as such Holder would have been entitled to receive if such Holder had
exercised this Warrant immediately prior to such reclassification or share
exchange (net of the applicable Exercise Price). The terms of any such
reclassification or share exchange shall include such terms so as to continue to
give to the Holder the right to receive the securities or property set forth in
this Section 9(b) upon any exercise following any such reclassification or share
exchange.

                           (c) If the Company, at any time while this Warrant is
outstanding, shall distribute to all holders of Common Stock (and not to holders
of this Warrant) evidences of its indebtedness or assets or rights or warrants
to subscribe for or purchase any security (excluding those referred to in
Sections 9(a), (b) and (d)), then in each such case the Exercise Price shall be

                                       4
<PAGE>

determined by multiplying the Exercise Price in effect immediately prior to the
record date fixed for determination of stockholders entitled to receive such
distribution by a fraction of which the denominator shall be the Exercise Price
determined as of the record date mentioned above, and of which the numerator
shall be such Exercise Price on such record date less the then fair market value
at such record date of the portion of such assets or evidence of indebtedness so
distributed applicable to one outstanding share of Common Stock as determined by
the Company's independent certified public accountants that regularly examine
the financial statements of the Company (an "Appraiser").

                           (d) If at any time the Company or any subsidiary
thereof, as applicable with respect to Common Stock Equivalents (as defined
below), shall issue shares of Common Stock or rights, warrants, options or other
securities or debt that is convertible into or exchangeable for shares of Common
Stock ("COMMON STOCK EQUIVALENTS"), entitling any person or entity to acquire
shares of Common Stock at a price per share less than the market price of the
Common Stock at the time of issuance, except with respect to a Board Approved
Transaction (as defined herein), forthwith upon such issue or sale, the Exercise
Price shall be reduced to the price (calculated to the nearest cent) determined
by multiplying the Exercise Price in effect immediately prior thereto by a
fraction, the numerator of which shall be the sum of (i) the number of shares of
Common Stock outstanding immediately prior to such issuance, and (ii) the number
of shares of Common Stock which the aggregate consideration received (or to be
received, assuming exercise or conversion in full of such Common Stock
Equivalents) for the issuance of such additional shares of Common Stock would
purchase at the Exercise Price, and the denominator of which shall be the sum of
the number of shares of Common Stock outstanding immediately after the issuance
of such additional shares. For purposes hereof, all shares of Common Stock that
are issuable upon conversion, exercise or exchange of Common Stock Equivalents
shall be deemed outstanding immediately after the issuance of such Common Stock
Equivalents. Such adjustment shall be made whenever such Common Stock or Common
Stock Equivalents are issued. However, upon the expiration of any Common Stock
Equivalents the issuance of which resulted in an adjustment in the Exercise
Price pursuant to this Section, the Exercise Price shall immediately upon such
expiration be recomputed and effective immediately upon such expiration be
increased to the price which it would have been (but reflecting any other
adjustments in the Exercise Price made pursuant to the provisions of this
Section after the issuance of such Common Stock Equivalents) had the adjustment
of the Exercise Price made upon the issuance of such Common Stock Equivalents
been made on the basis of offering for subscription or purchase only that number
of shares of the Common Stock actually purchased upon the exercise of such
Common Stock Equivalents actually exercised. Notwithstanding anything herein to
the contrary, issuances of any stock or stock options under any bona fide
employee benefit plan or compensation arrangement of the Company, shall not be
subject to the provisions of this Section.

                           A "Board Approved Transaction" is a transaction
involving a strategic alliance, acquisition of stock or assets, merger,
collaboration, joint venture, partnership or similar arrangement of the Company
with another corporation, partnership or other business entity (A) which is
engaged in a business similar complementary or related to the business of the
Company or (B) pursuant to which the Company issues securities with the primary
purpose to directly or indirectly acquire, license or otherwise become entitled
to use technology relevant to or useful in

                                       5
<PAGE>

the Company's business, so long as the Company's Board of Directors by
resolution duly adopted approves such transaction in accordance with its duties
under applicable law.

                           (e) In case of any (1) merger or consolidation of the
Company with or into another Person, or (2) sale by the Company of more than
one-half of the assets of the Company (on a market value basis) in one or a
series of related transactions, or (3) tender or other offer or exchange
(whether by the Company or another Person) pursuant to which holders of Common
Stock are permitted to tender or exchange their shares for other securities,
stock, cash or property of the Company or another Person; then the Holder shall
have the right thereafter to (A) exercise this Warrant for the shares of stock
and other securities, cash and property receivable upon or deemed to be held by
holders of Common Stock following such merger, consolidation or sale, and the
Holder shall be entitled upon such event or series of related events to receive
such amount of securities, cash and property as the Common Stock for which this
Warrant could have been exercised immediately prior to such merger,
consolidation or sales would have been entitled, (B) in the case of a merger or
consolidation, require the surviving entity to issue to the Holder a warrant
entitling the Holder to acquire shares of such entity's common stock, which
warrant shall have terms identical MUTATIS MUTANDIS (including with respect to
exercise) to the terms of this Warrant and shall be entitled to all of the
rights and privileges set forth herein and the agreements pursuant to which this
Warrant was issued (including, without limitation, as such rights relate to the
acquisition, transferability, registration and listing of such shares of stock
or other securities issuable upon exercise thereof), or (C) in the event of an
exchange or tender offer or other transaction contemplated by clause (3) of this
Section 9(e), tender or exchange this Warrant for such securities, stock, cash
and other property receivable upon or deemed to be held by holders of Common
Stock that have tendered or exchanged their shares of Common Stock following
such tender or exchange, and the Holder shall be entitled upon such exchange or
tender to receive such amount of securities, cash and property as the shares of
Common Stock for which this Warrant could have been exercised immediately prior
to such tender or exchange would have been entitled as would have been issued
(net of the applicable Exercise Price). In the case of clause (B), the exercise
price applicable for the newly issued warrant shall be based upon the amount of
securities, cash and property that each share of Common Stock would receive in
such transaction and the Exercise Price immediately prior to the effectiveness
or closing date for such transaction. The terms of any such merger, sale,
consolidation, tender or exchange shall include such terms so as continue to
give the Holder the right to receive the securities, cash and property set forth
in this Section upon any conversion or exercise following such event. This
provision shall similarly apply to successive such events.

                           (f) For the purposes of this Section 9, the following
clauses shall also be applicable:

                                    (i) RECORD DATE. In case the Company shall
take a record of the holders of its Common Stock for the purpose of entitling
them (A) to receive a dividend or other distribution payable in Common Stock or
in securities convertible or exchangeable into shares of Common Stock, or (B) to
subscribe for or purchase Common Stock or securities convertible or exchangeable
into shares of Common Stock, then such record date shall be deemed to be the
date of the issue or sale of the shares of Common Stock deemed to have been
issued or sold upon the declaration of such dividend or the making of such other
distribution or the date of the granting of such right of subscription or
purchase, as the case may be.

                                       6
<PAGE>

                                    (ii) TREASURY SHARES. The number of shares
of Common Stock outstanding at any given time shall not include shares owned or
held by or for the account of the Company, and the disposition of any such
shares shall be considered an issue or sale of Common Stock.

                           (g) All calculations under this Section 9 shall be
made to the nearest cent or the nearest 1/100th of a share, as the case may be.

                           (h) If (i) the Company shall declare a dividend (or
any other distribution) on its Common Stock; or (ii) the Company shall declare a
special nonrecurring cash dividend on or a redemption of its Common Stock; or
(iii) the Company shall authorize the granting to all holders of the Common
Stock rights or warrants to subscribe for or purchase any shares of capital
stock of any class or of any rights; or (iv) the approval of any stockholders of
the Company shall be required in connection with any reclassification of the
Common Stock, any consolidation or merger to which the Company is a party, any
sale or transfer of all or substantially all of the assets of the Company, or
any compulsory share exchange whereby the Common Stock is converted into other
securities, cash or property; or (v) the Company shall authorize the voluntary
dissolution, liquidation or winding up of the affairs of the Company, then the
Company shall cause to be mailed to each Holder at their last addresses as they
shall appear upon the Warrant Register, at least 30 calendar days prior to the
applicable record or effective date hereinafter specified, a notice stating (x)
the date on which a record is to be taken for the purpose of such dividend,
distribution, redemption, grant of rights or warrants, or if a record is not to
be taken, the date as of which the holders of Common Stock of record to be
entitled to such dividend, distributions, redemption, rights or warrants are to
be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or
close, and the date as of which it is expected that holders of Common Stock of
record shall be entitled to exchange their shares of Common Stock for
securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer, share exchange, dissolution, liquidation
or winding up; provided, however, that the failure to mail such notice or any
defect therein or in the mailing thereof shall not affect the validity of the
corporate action required to be specified in such notice.

                  10. PAYMENT OF EXERCISE PRICE. The Holder shall pay the
Exercise Price in one of the following manners:

                           (a) CASH EXERCISE. The Holder may deliver immediately
available funds; or

                           (b) CASHLESS EXERCISE. At any time after the earlier
to occur of the SEC Effective Date (as defined in the Registration Rights
Agreement) and the date the initial registration statement filed pursuant to the
Registration Rights Agreement is declared effective by the Commission, when a
registration statement covering the resale of the Warrant Shares and naming the
Holder as a selling stockholder thereunder is not then effective, the Holder may
surrender this Warrant to the Company together with a notice of cashless
exercise, in which event the Company shall issue to the Holder the number of
Warrant Shares determined as follows:

                                       7
<PAGE>

                           X = Y [(A-B)/A]

                  where:

                           X = the number of Warrant Shares to be issued
                  to the Holder.

                           Y = the number of Warrant Shares with respect to
                  which this Warrant is being exercised.

                           A = the average of the closing sale prices of the
                  Common Stock for the five (5) trading days immediately prior
                  to (but not including) the Date of Exercise.

                           B = the Exercise Price.

For purposes of Rule 144 promulgated under the Securities Act, it is intended,
understood and acknowledged that the Warrant Shares issued in a cashless
exercise transaction shall be deemed to have been acquired by the Holder, and
the holding period for the Warrant Shares shall be deemed to have been
commenced, on the issue date of this Warrant.

                  11. CERTAIN EXERCISE RESTRICTIONS.

                           (a) Notwithstanding anything to the contrary
contained herein, the number of shares of Common Stock that may be acquired by
the Holder upon exercise pursuant to the terms hereof shall not exceed a number
that, when added to the total number of shares of Common Stock deemed
beneficially owned by such Holder (other than by virtue of the ownership of
securities or rights to acquire securities that have limitations on the Holder's
right to convert, exercise or purchase similar to the limitation set forth
herein), together with all shares of Common Stock deemed beneficially owned
(other than by virtue of the ownership of securities or rights to acquire
securities that have limitation set forth herein) by the Holder's "affiliates"
(as defined in Rule 144 of the Securities Act) ("Aggregation Parties"), that
would be aggregated for purposes of determining whether a group under Section
13(d) of the Securities Exchange Act of 1934, as amended, exists would exceed
9.99% of the total issued and outstanding shares of the Common Stock (the
"Restricted Ownership Percentage"). Each Holder shall have the right (w) at any
time and from time to time to reduce its Restricted Ownership Percentage
immediately upon notice to the Company and (x) (subject to waiver) at any time
and from time to time, to increase its Restricted Ownership Percentage
immediately in the event of the announcement as pending or planned, of a merger
or consolidation of the Company, a sale of all or substantially all of the
assets of the Company or the acquisition by any third party (and/or such party's
Aggregation Parties) of at least 51% of the Company's outstanding Common Stock.

                           (b) The Holder covenants at all times on each day
(each such day being referred to as a "Covenant Day") as follows: during the
balance of such Covenant Day and the succeeding sixty-one (61) days (the balance
of such Covenant Day and the succeeding 61 days being referred to as the
"Covenant Period") such Holder will not acquire shares of Common Stock pursuant
to any right (including exercise of this Warrant) existing at the commencement
of

                                       8
<PAGE>

the Covenant Period to the extent the number of shares so acquired by such
Holder and its Aggregation Parties (ignoring all dispositions) would exceed:

                           (x)      the Restricted Ownership Percentage of the
                                    total number of shares of Common Stock
                                    outstanding at the commencement of the
                                    Covenant Period;

                           MINUS

                           (y)      the number of share of Common Stock owned by
                                    such Holder and its Aggregation Parties at
                                    the commencement of the Covenant Period.

                  A new and independent covenant will be deemed to be given by
the Holder as of each moment of each Covenant Day. No covenant will terminate,
diminish or modify any other covenant. The Holder agrees to comply with each
such covenant.

                  The Company's obligation to issue shares of Common Stock which
would exceed such limited shall be suspended to the extent necessary until such
time, if any, as shares of Common Stock may be issued in compliance with such
restrictions.

                  12. FRACTIONAL SHARES. The Company shall not be required to
issue or cause to be issued fractional Warrant Shares on the exercise of this
Warrant. The number of full Warrant Shares which shall be issuable upon the
exercise of this Warrant shall be computed on the basis of the aggregate number
of Warrant Shares purchasable on exercise of this Warrant so presented. If any
fraction of a Warrant Share would, except for the provisions of this Section, be
issuable on the exercise of this Warrant, the Company shall pay an amount in
cash equal to the Exercise Price multiplied by such fraction.

                  13. NOTICES. Any and all notices or other communications or
deliveries hereunder shall be in writing and shall be deemed given and effective
on the earliest of (i) the date of transmission, if such notice or communication
is delivered via facsimile at the facsimile telephone number specified in this
Section prior to 6:30 p.m. (New York City time) on a business day, (ii) the
business day after the date of transmission, if such notice or communication is
delivered via facsimile at the facsimile telephone number specified in this
Section later than 6:30 p.m. (New York City time) on any date and earlier than
11:59 p.m. (New York City time) on such date, (iii) the business day following
the date of mailing, if sent by nationally recognized overnight courier service,
or (iv) upon actual receipt by the party to whom such notice is required to be
given. The addresses for such communications shall be: (i) if to the Company, to
3155 Porter Drive, Palo Alto, California 94304, with a copy to Ropes & Gray, One
International Place, Boston, Massachusetts, 02110, Attention: Geoffrey B. Davis,
Esq., (facsimile number (617) 951-7050), or (ii) if to the Holder, to the Holder
at the address or facsimile number appearing on the Warrant Register or such
other address or facsimile number as the Holder may provide to the Company in
accordance with this Section.

                                       9
<PAGE>

                  14. WARRANT AGENT. The Company shall serve as warrant agent
under this Warrant. Upon thirty (30) days' notice to the Holder, the Company may
appoint a new warrant agent. Any corporation into which the Company or any new
warrant agent may be merged or any corporation resulting from any consolidation
to which the Company or any new warrant agent shall be a party or any
corporation to which the Company or any new warrant agent transfers
substantially all of its corporate trust or shareholders services business shall
be a successor warrant agent under this Warrant without any further act. Any
such successor warrant agent shall promptly cause notice of its succession as
warrant agent to be mailed (by first class mail, postage prepaid) to the Holder
at the Holder's last address as shown on the Warrant Register.

                  15. MISCELLANEOUS.

                           (a) This Warrant shall be binding on and inure to the
benefit of the parties hereto and their respective successors and assigns.
Subject to the Subscription Agreement and applicable securities laws, this
Warrant shall be freely transferable subject to applicable Securities Laws. This
Warrant may be amended only in writing signed by the Company and the Holder and
their successors and assigns.

                           (b) Subject to Section 15(a), above, nothing in this
Warrant shall be construed to give to any person or corporation other than the
Company and the Holder any legal or equitable right, remedy or cause under this
Warrant. This Warrant shall inure to the sole and exclusive benefit of the
Company and the Holder.

                           (c) The corporate laws of the State of Delaware shall
govern all issues concerning the relative rights of the Company and its
stockholders. All other questions concerning the construction, validity,
enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New
York, without regard to the principles of conflicts of law thereof. The Company
and the Holder hereby irrevocably submit to the exclusive jurisdiction of the
state and federal courts sitting in the City of New York, borough of Manhattan,
for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim
that it is not personally subject to the jurisdiction of any such court, or that
such suit, action or proceeding is improper. Each of the Company and the Holder
hereby irrevocably waives personal service of process and consents to process
being served in any such suit, action or proceeding by certified mail, return
receipt requested, and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall
be deemed to limit in any way any right to serve process in any manner permitted
by law.

                           (d) The headings herein are for convenience only, do
not constitute a part of this Warrant and shall not be deemed to limit or affect
any of the provisions hereof.

                           (e) In case any one or more of the provisions of this
Warrant shall be invalid or unenforceable in any respect, the validity and
enforceability of the remaining terms and provisions of this Warrant shall not
in any way be affected or impaired thereby and the parties will attempt in good
faith to agree upon a valid and enforceable provision which shall be

                                       10
<PAGE>

a commercially reasonable substitute therefor, and upon so agreeing, shall
incorporate such substitute provision in this Warrant.

                  IN WITNESS WHEREOF, the Company has caused this Warrant to be
duly executed by its authorized officer as of the date first indicated above.

                                  STEMCELLS, INC.

                                  By: /s/ Martin M. McGlynn
                                     -------------------------------------------

                                  Name: Martin M. McGlynn
                                       -----------------------------------------

                                  Title: President, Chief Executive Officer
                                        ----------------------------------------

                                       11
<PAGE>

                        FORM OF ELECTION TO PURCHASE

(To be executed by the Holder to exercise the right to purchase shares of Common
Stock under the foregoing Warrant)

To StemCells, Inc:

                  In accordance with the Warrant enclosed with this Form of
Election to Purchase, the undersigned hereby irrevocably elects to purchase
_____________ shares of common stock, $.01 par value per share, of STEMCELLS,
INC. (the "Common Stock") and , if such Holder is not utilizing the cashless
exercise provisions set forth in this Warrant, encloses herewith $________ in
cash, certified or official bank check or checks, which sum represents the
aggregate Exercise Price (as defined in the Warrant) for the number of shares of
Common Stock to which this Form of Election to Purchase relates, together with
any applicable taxes payable by the undersigned pursuant to the Warrant.

                  The undersigned requests that certificates for the shares of
Common Stock issuable upon this exercise be issued in the name of

                        PLEASE INSERT SOCIAL SECURITY OR
                        TAX IDENTIFICATION NUMBER

                        --------------------------------------------------------

--------------------------------------------------------------------------------
                        (Please print name and address)

                  If the number of shares of Common Stock issuable upon this
exercise shall not be all of the shares of Common Stock which the undersigned is
entitled to purchase in accordance with the enclosed Warrant, the undersigned
requests that a New Warrant (as defined in the Warrant) evidencing the right to
purchase the shares of Common Stock not issuable pursuant to the exercise
evidenced hereby be issued in the name of and delivered to:

--------------------------------------------------------------------------------
                         (Please print name and address)

                                       12
<PAGE>

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

Dated:            ,               Name of Holder:
       -----------  -------

                                     (Print)

                                     (By:)
                                     (Name:)
                                     (Title:)

                                     (Signature must conform in all respects to
                                     name of holder as specified on the face of
                                     the Warrant)

                                       13
<PAGE>

                               FORM OF ASSIGNMENT

           [To be completed and signed only upon transfer of Warrant]

                  FOR VALUE RECEIVED, the undersigned hereby sells, assigns and
transfers unto ________________________________ the right represented by the
within Warrant to purchase ____________ shares of Common Stock of StemCells,
Inc. to which the within Warrant relates and appoints ________________ attorney
to transfer said right on the books of StemCells, Inc. with full power of
substitution in the premises.

Dated:

---------------, ----

                               ---------------------------------------
                               (Signature must conform in all respects to name
                               of holder as specified on the face of the
                               Warrant)

                               ---------------------------------------
                               Address of Transferee

                               ---------------------------------------

                               ---------------------------------------

In the presence of:

--------------------------<PAGE>

                                                                    EXHIBIT 4.15

NEITHER THESE SECURITIES NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE
EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR
THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES
ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS THEREUNDER AND IN
COMPLIANCE WITH APPLICABLE STATE SECURITIES OR BLUE SKY LAWS.

Right to Purchase the Specified Number of Shares of Common Stock of StemCells,
Inc.

                                 STEMCELLS, INC.

                     COMMON STOCK PURCHASE WARRANT, CLASS A

NO. A-3

                  STEMCELLS, INC., a Delaware corporation (the "Company"),
hereby certifies that, for value received, Millennium Partners, L.P. or its
registered assigns (the "Holder"), is entitled, subject to the terms set forth
below, to purchase from the Company at any time or from time to time during the
Exercise Period (such capitalized term and all other capitalized terms used
herein having the respective meanings provided herein), the Specified Number of
fully paid and nonassessable shares of Common Stock at a purchase price per
share equal to the Purchase Price. The number of such shares of Common Stock is
subject to adjustment as provided in this Warrant.

                  As used herein the following terms, unless the context
otherwise requires, have the following respective meanings:

                  "Adjustment Date" means any of the First Adjustment Date and
each date which occurs every 90 days after the First Adjustment Date through and
including the date which is 810 days after the Issuance Date.

                  "Adjustment Factor" means 1.015.

                  "Adjustment Shares" means the number of shares of Common
Stock, determined on each Adjustment Date in accordance with Section 1.3(a), to
be added to the Specified Number on each Adjustment Date in accordance with
Section 1.3(b).

                  "Auditors" means Ernst & Young LLP or such other firm of
independent public accountants of recognized national standing as shall have
been engaged by the Company to audit its financial statements.
<PAGE>

                  "Average Market Price" means the arithmetic average of the ten
(10) lowest Market Prices during the applicable Measurement Period.

                  "Cash and Cash Equivalent Balances" of any person on any date
shall be determined from such person's books maintained in accordance with
Generally Accepted Accounting Principles, and means, without duplication, the
sum of (1) the cash accrued by such person and its subsidiaries on a
consolidated basis on such date and available for use by such person and its
subsidiaries on such date and (2) all assets which would, on a consolidated
balance sheet of such person and its subsidiaries prepared as of such date in
accordance with Generally Accepted Accounting Principles, be classified as cash
or cash equivalents, less the amount thereof which secures any outstanding
indebtedness of such person or its subsidiaries.

                  "Callable Warrant" means the Callable Warrant, issued by the
Company pursuant to the Subscription Agreement.

                  "Class A Warrant Shares" means those shares of Common Stock
issued upon exercise of this Warrant (subject to equitable adjustment from time
to time on terms reasonably acceptable to the Holder for stock splits, stock
dividends, combinations, recapitalizations, reclassifications, distributions,
Tender Offers and similar events occurring after the Issuance Date).

                  "Commission" means the Securities and Exchange Commission.

                  "Common Shares Held" as of any date means the sum of (1) the
number of Initial Shares which are then held by the Holder plus (2) the number
of Class A Warrant Shares which are then held by the Holder plus (3) the number
of shares of Common Stock which are issuable upon exercise of this Warrant
immediately prior to the determination of the number of Adjustment Shares
pursuant to Section 1.3(a).

                  "Common Stock" means the Company's Common Stock, $.01 par
value per share, as authorized on the date hereof, and any other securities into
which or for which the Common Stock may be converted or exchanged pursuant to a
plan of recapitalization, reorganization, merger, sale of assets or otherwise.

                  "Company" shall include StemCells,  Inc., a Delaware
corporation, and any corporation that shall succeed to or assume the obligations
of StemCells, Inc. hereunder in accordance with the terms hereof.

                  "Control Notice" means a notice given by the Company to the
Holder, in accordance with Section 1.5(b), (i) stating that a Share Limitation
Event has occurred by reason of events which are not solely within the control
of the Company and (ii) enclosing an executed copy of an Auditors'
Determination.

                  "Exercise Period" means the period commencing on the First
Adjustment Date and ending thirty (30) days following the Last Adjustment Date.

                  "First Adjustment Date" means the date which is 180 days after
the Issuance Date.

                                       2
<PAGE>

                  "Generally Accepted Accounting Principles" for any person
means the generally accepted accounting principles and practices applied by such
person from time to time in the preparation of its audited financial statements.

                  "Holder Repurchase Price" means, for each share of Common
Stock which may not be issued upon exercise of this Warrant by reason of the
Shareholder Approval Rule in accordance with Section 1.4 (c), 120% of the
greater of: (x) the arithmetic average of the Market Price on each of the five
consecutive Trading Days immediately prior to and including the expiration of
the 75-day period referred to in Section 1.4(c) or the Repurchase Date referred
to in Section 1.4(b), as the case may be, (y) the arithmetic average of the
Market Price on each of the five consecutive Trading Days immediately prior to
the repurchase date pursuant to Section 1.4(c) or Section 1.4(b) and (z) if
determined prior to the First Adjustment Date, the price per share paid by the
Holder for the shares of Common Stock purchased on the Issuance Date pursuant to
the Subscription Agreement or, if determined on or after the First Adjustment
Date, the most recent Adjustment Price (subject to equitable adjustment from
time to time on terms reasonably acceptable to the Holder for stock splits,
stock dividends, combinations, recapitalizations, reclassifications,
distributions, Tender Offers and similar events occurring after the Issuance
Date).

                  "Initial Shares" means those shares of Common Stock purchased
by the Holder on or about the Issuance Date pursuant to the Subscription
Agreement (subject to equitable adjustment from time to time on terms reasonably
acceptable to the Holder for stock splits, stock dividends, combinations,
recapitalizations, reclassifications, distributions, Tender Offers and similar
events occurring after the Issuance Date), excluding shares issuable pursuant to
the Callable Warrant.

                  "Issuance Date" means the first date of original issuance of
this Warrant.

                  "Market Price" of the Common Stock on any date means the
closing bid price for one share of Common Stock on such date on the first
applicable among the following: (a) the national securities exchange on which
the shares of Common Stock are listed which constitutes the principal securities
market for the Common Stock, (b) the Nasdaq, if the Nasdaq constitutes the
principal market for the Common Stock on such date, or (c) the Nasdaq SmallCap,
if the Nasdaq SmallCap constitutes the principal securities market for the
Common Stock on such date, in any such case as reported by Bloomberg, LP.;
provided, however, that if during any Measurement Period or other period during
which the Market Price is being determined:

                           (i) The Company shall declare or pay a dividend or
                  make a distribution to all holders of the outstanding Common
                  Stock in shares of Common Stock or fix any record date for any
                  such action, then the Market Price for each day in such
                  Measurement Period or such other period which day is prior to
                  the earlier of (1) the date fixed for the determination of
                  stockholders entitled to receive such dividend or other
                  distribution and (2) the date on which ex-dividend trading in
                  the Common Stock with respect to such dividend or distribution
                  begins shall be reduced by multiplying the Market Price
                  (determined without regard to this proviso) for each such day
                  in such Measurement Period or such other period by a fraction,
                  the numerator of which shall be the number of shares of Common

                                       3
<PAGE>

                  Stock outstanding at the close of business on the earlier of
                  (1) the record date fixed for such determination and (2) the
                  date on which ex-dividend trading in the Common Stock with
                  respect to such dividend or distribution begins and the
                  denominator of which shall be the sum of such number of shares
                  and the total number of shares constituting such dividend or
                  other distribution;

                           (ii) The Company shall issue rights or warrants to
                  all holders of its outstanding shares of Common Stock, or fix
                  a record date for such issuance, which rights or warrants
                  entitle such holders (for a period expiring within forty-five
                  (45) days after the date fixed for the determination of
                  stockholders entitled to receive such rights or warrants) to
                  subscribe for or purchase shares of Common Stock at a price
                  per share less than the Market Price (determined without
                  regard to this proviso) for any day in such Measurement Period
                  or such other period which day is prior to the end of such
                  45-day period, then the Market Price for each such day shall
                  be reduced so that the same shall equal the price determined
                  by multiplying the Market Price (determined without regard to
                  this proviso) by a fraction, the numerator of which shall be
                  the number of shares of Common Stock outstanding at the close
                  of business on the record date fixed for the determination of
                  stockholders entitled to receive such rights or warrants plus
                  the number of shares which the aggregate offering price of the
                  total number of shares so offered would purchase at such
                  Market Price, and the denominator of which shall be the number
                  of shares of Common Stock outstanding on the close of business
                  on such record date plus the total number of additional shares
                  of Common Stock so offered for subscription or purchase. In
                  determining whether any rights or warrants entitle the holders
                  to subscribe for or purchase shares of Common Stock at less
                  than the Market Price (determined without regard to this
                  proviso), and in determining the aggregate offering price of
                  such shares of Common Stock, there shall be taken into account
                  any consideration received for such rights or warrants, the
                  value of such consideration, if other than cash, to be
                  determined in good faith by a resolution of the Board of
                  Directors of the Company;

                           (iii) The outstanding shares of Common Stock shall be
                  subdivided into a greater number of shares of Common Stock or
                  a record date for any such subdivision shall be fixed, then
                  the Market Price of the Common Stock for each day in such
                  Measurement Period or such other period which day is prior to
                  the earlier of (1) the day upon which such subdivision becomes
                  effective and (2) the date on which ex-dividend trading in the
                  Common Stock with respect to such subdivision begins shall be
                  proportionately reduced, and conversely, in case the
                  outstanding shares of Common Stock shall be combined into a
                  smaller number of shares of Common Stock, the Market Price for
                  each day in such Measurement Period or such other period which
                  day is prior to the earlier of (1) the date on which such
                  combination becomes effective and (2) the date on which
                  trading in the Common Stock on a basis which gives effect to
                  such combination begins, shall be proportionately increased;

                                       4
<PAGE>

                           (iv) The Company shall, by dividend or otherwise,
                  distribute to all holders of its Common Stock shares of any
                  class of capital stock of the Company (other than any
                  dividends or distributions to which clause (i) of this proviso
                  applies) or evidences of its indebtedness, cash or other
                  assets (including securities, but excluding any rights or
                  warrants referred to in clause (ii) of this proviso and
                  dividends and distributions paid exclusively in cash and
                  excluding any capital stock, evidences of indebtedness, cash
                  or assets distributed upon a merger or consolidation) (the
                  foregoing hereinafter in this clause (iv) of this proviso
                  called the "Securities"), or fix a record date for any such
                  distribution, then, in each such case, the Market Price for
                  each day in such Measurement Period or such other period which
                  day is prior to the earlier of (1) the record date for such
                  distribution and (2) the date on which ex-dividend trading in
                  the Common Stock with respect to such distribution begins
                  shall be reduced so that the same shall be equal to the price
                  determined by multiplying the Market Price (determined without
                  regard to this proviso) by a fraction, the numerator of which
                  shall be the Market Price (determined without regard to this
                  proviso) for such date less the fair market value (as
                  determined in good faith by resolution of the Board of
                  Directors of the Company) on such date of the portion of the
                  Securities so distributed or to be distributed applicable to
                  one share of Common Stock and the denominator of which shall
                  be the Market Price (determined without regard to this
                  proviso) for such date. If the Board of Directors of the
                  Company determines the fair market value of any distribution
                  for purposes of this clause (iv) by reference to the actual or
                  when issued trading market for any Securities comprising all
                  or part of such distribution, it must in doing so consider the
                  prices in such market on the same day for which an adjustment
                  in the Market Price is being determined.

                           For purposes of this clause (iv) and clauses (i) and
                  (ii) of this proviso, any dividend or distribution to which
                  this clause (iv) is applicable that also includes shares of
                  Common Stock, or rights or warrants to subscribe for or
                  purchase shares of Common Stock to which clause (i) or (ii) of
                  this proviso applies (or both), shall be deemed instead to be
                  (1) a dividend or distribution of the evidences of
                  indebtedness, assets, shares of capital stock, rights or
                  warrants other than such shares of Common Stock or rights or
                  warrants to which clause (i) or (ii) of this proviso applies
                  (and any Market Price reduction required by this clause (iv)
                  with respect to such dividend or distribution shall then be
                  made) immediately followed by (2) a dividend or distribution
                  of such shares of Common Stock or such rights or warrants (and
                  any further Market Price reduction required by clauses (i) and
                  (ii) of this proviso with respect to such dividend or
                  distribution shall then be made), except that any shares of
                  Common Stock included in such dividend or distribution shall
                  not be deemed "outstanding at the close of business on the
                  date fixed for such determination" within the meaning of
                  clause (i) of this proviso;

                           (v) The Company or any subsidiary of the Company
                  shall (x) by dividend or otherwise, distribute to all holders
                  of its Common Stock cash in (or fix any record date for any
                  such distribution), or (y) repurchase or reacquire shares of
                  its Common Stock for, in either case, an aggregate amount
                  that,

                                       5
<PAGE>

                  combined with (1) the aggregate amount of any other such
                  distributions to all holders of its Common Stock made
                  exclusively in cash after the Issuance Date and within the 12
                  months preceding the date of payment of such distribution, and
                  in respect of which no adjustment pursuant to this clause (v)
                  has been made, (2) the aggregate amount of any cash plus the
                  fair market value (as determined in good faith by a resolution
                  of the Board of Directors of the Company) of consideration
                  paid in respect of any repurchase or other reacquisition by
                  the Company or any subsidiary of the Company of any shares of
                  Common Stock made after the Issuance Date and within the 12
                  months preceding the date of payment of such distribution or
                  making of such repurchase or reacquisition, as the case may
                  be, and in respect of which no adjustment pursuant to this
                  clause (v) has been made, and (3) the aggregate of any cash
                  plus the fair market value (as determined in good faith by a
                  resolution of the Board of Directors of the Company) of
                  consideration payable in respect of any Tender Offer by the
                  Company or any of its subsidiaries for all or any portion of
                  the Common Stock concluded within the 12 months preceding the
                  date of payment of such distribution or completion of such
                  repurchase or reacquisition, as the case may be, and in
                  respect of which no adjustment pursuant to clause (vi) of this
                  proviso has been made (such aggregate amount combined with the
                  amounts in clauses (1), (2) and (3) above being the "Combined
                  Amount"), exceeds 10% of the product of the Market Price
                  (determined without regard to this proviso) for any day in
                  such Measurement Period or such other period which day is
                  prior to the earlier of (A) the record date with respect to
                  such distribution and (B) the date on which ex-dividend
                  trading in the Common Stock with respect to such distribution
                  begins or the date of such repurchase or reacquisition, as the
                  case may be, times the number of shares of Common Stock
                  outstanding on such date, then, and in each such case, the
                  Market Price for each such day shall be reduced so that the
                  same shall equal the price determined by multiplying the
                  Market Price (determined without regard to this proviso) for
                  such day by a fraction (i) the numerator of which shall be
                  equal to the Market Price (determined without regard to this
                  proviso) for such day less an amount equal to the quotient of
                  (x) the excess of such Combined Amount over such 10% and (y)
                  the number of shares of Common Stock outstanding on such day
                  and (ii) the denominator of which shall be equal to the Market
                  Price (determined without regard to this proviso) for such
                  day; or

                           (vi) A Tender Offer made by the Company or any of its
                  subsidiaries for all or any portion of the Common Stock shall
                  expire and such Tender Offer (as amended upon the expiration
                  thereof) shall require the payment to stockholders (based on
                  the acceptance (up to any maximum specified in the terms of
                  the Tender Offer) of Purchased Shares (as defined below)) of
                  an aggregate consideration having a fair market value (as
                  determined in good faith by resolution of the Board of
                  Directors of the Company) that combined together with (1) the
                  aggregate of the cash plus the fair market value (as
                  determined in good faith by a resolution of the Board of
                  Directors of the Company), as of the expiration of such Tender
                  Offer, of consideration payable in respect of any other Tender
                  Offers, by the Company or any of its subsidiaries for all or
                  any portion of

                                       6
<PAGE>

                  the Common Stock expiring within the 12 months preceding the
                  expiration of such Tender Offer and in respect of which no
                  adjustment pursuant to this clause (vi) has been made, (2) the
                  aggregate amount of any cash plus the fair market value (as
                  determined in good faith by a resolution of the Board of
                  Directors of the Company) of consideration paid in respect of
                  any repurchase or other reacquisition by the Company or any
                  subsidiary of the Company of any shares of Common Stock made
                  after the Issuance Date and within the 12 months preceding the
                  expiration of such Tender Offer and in respect of which no
                  adjustment pursuant to clause (v) of this proviso has been
                  made, and (3) the aggregate amount of any distributions to all
                  holders of Common Stock made exclusively in cash within 12
                  months preceding the expiration of such Tender Offer and in
                  respect of which no adjustment pursuant to clause (v) of this
                  proviso has been made, exceeds 10% of the product of the
                  Market Price (determined without regard to this proviso) for
                  any day in such period times the number of shares of Common
                  Stock outstanding on such day, then, and in each such case,
                  the Market Price for such day shall be reduced so that the
                  same shall equal the price determined by multiplying the
                  Market Price (determined without regard to this proviso) for
                  such day by a fraction, the numerator of which shall be the
                  number of shares of Common Stock outstanding on such day
                  multiplied by the Market Price (determined without regard to
                  this proviso) for such day and the denominator of which shall
                  be the sum of (x) the fair market value (determined as
                  aforesaid) of the aggregate consideration payable to
                  stockholders based on the acceptance (up to any maximum
                  specified in the terms of the Tender Offer) of all shares
                  validly tendered and not withdrawn as of the last time tenders
                  could have been made pursuant to such Tender Offer (the
                  "Expiration Time") (the shares deemed so accepted, up to any
                  such maximum, being referred to as the "Purchased Shares") and
                  (y) the product of the number of shares of Common Stock
                  outstanding (less any Purchased Shares) on such day times the
                  Market Price (determined without regard to this proviso) of
                  the Common Stock on the Trading Day next succeeding the
                  Expiration Time. If the application of this clause (vi) to any
                  Tender Offer would result in an increase in the Market Price
                  (determined without regard to this proviso) for any trade, no
                  adjustment shall be made for such Tender Offer under this
                  clause (vi) for such day.

                  "Measurement Period" means, with respect to any Adjustment
Date, the period of 30 consecutive Trading Days ending on the Trading Day prior
to such Adjustment Date.

                  "Nasdaq" means the Nasdaq National Market.

                  "Nasdaq SmallCap" means the Nasdaq SmallCap Market.

                  "1934 Act" means the Securities Exchange Act of 1934, as
amended.

                  "1933 Act" means the Securities Act of 1933, as amended.

                  "Other Securities" refers to any stock (other than Common
Stock) and other securities of the Company or any other person (corporate or
otherwise) which the Holder at any

                                       7
<PAGE>

time shall be entitled to receive, or shall have received, on the exercise of
this Warrant, in lieu of or in addition to Common Stock, or which at any time
shall be issuable or shall have been issued in exchange for or in replacement of
Common Stock or Other Securities pursuant to Section 4.

                  "Purchase Price" means the greater of (x) $.01 per share or
(y) the par value per share of the Common Stock.

                  "Purchased Securities" as of any date means (1) the Initial
Shares which are then held by the Holder, (2) the Class A Warrant Shares which
are then held by the Holder and (3) this Warrant.

                  "Registration Rights Agreement" means the Registration Rights
Agreement, dated as of the date hereof, by and between the Company and the
original Holder of this Warrant, as amended from time to time in accordance with
its terms.

                  "Registration Statement" shall have the meaning provided in
the Registration Rights Agreement.

                  "Repurchase Date" means the date of repurchase by the Company
of the Securities pursuant to Section 1.4.

                  "Repurchase Notice" means a notice given by the Company to the
Holder pursuant to Section 1.4(b) exercising the Company's right to repurchase
all of the Securities pursuant to Section 1.4(b) which states (1) the number of
shares of Common Stock (including shares issuable upon exercise of this Warrant)
which are to be repurchased, (2) the Repurchase Price and the formula for
determining the same, determined in accordance herewith and (3) the Repurchase
Date.

                  "Repurchase Price" means, for each share of Common Stock
repurchased pursuant to Section 1.4, the product of (x) the arithmetic average
of the Market Price on each of the five consecutive Trading Days ending on and
including the Adjustment Date following which the Repurchase Notice is given
times (y) the Adjustment Factor.

                  "Share Limit" means 4,291,642 shares of Common Stock (subject
to equitable adjustment from time to time on terms reasonably acceptable to the
Holder for stock splits, stock dividends, combinations, recapitalizations,
reclassifications, distributions, Tender Offers and similar events occurring
after the Issuance Date).

                  "Share Limitation Event" means a time at which the Company is
unable to issue all shares of Common Stock otherwise required to be issued upon
exercise of this Warrant by reason of the restrictions set forth in the
Shareholder Approval Rule and the Company has not obtained a waiver thereof.

                  "Shareholder Approval" shall mean the approval by a majority
of the votes cast by the holders of shares of Common Stock (in person or by
proxy) at a meeting of the stockholders of the Company (duly convened at which a
quorum was present), or a unanimous written consent of holders of shares of
Common Stock given without a meeting, of the issuance by the Company of 20% or
more of the Common Stock of the Company outstanding on the

                                       8
<PAGE>

Issuance Date for less than the greater of the book or market value of such
Common Stock, as and to the extent required under the Shareholder Approval Rule.

                  "Shareholder Approval Rule" means Rule 4350(i)(1)(D) of Nasdaq
as in effect from time to time or any successor, replacement or similar rule or
regulation of Nasdaq or any other principal securities market on which the
Common Stock is listed for trading.

                  "Specified Number" means the number of shares of Common Stock
for which this Warrant is exercisable from time to time as determined in
accordance with Section 1.3.

                  "Subscription Agreement" means the Subscription Agreement,
dated as of June 21, 2001, by and between the Company and the original Holder of
this Warrant, as amended from time to time in accordance with its terms.

                  "Tender Offer" means a tender offer or exchange offer.

                  "Total Common Shares" as of any date means the sum of (1) the
number of Initial Shares plus (2) the number of Class A Warrant Shares plus (3)
the number of shares of Common Stock issued pursuant to the Callable Warrant.

                  "Trading Day" means a day on which the principal securities
market for the Common Stock is open for general trading of securities.

                  1. EXERCISE OF WARRANT.

                  1.1 EXERCISE. Subject to the limitations on exercises in
Sections 1.2 and 1.4(a), this Warrant may be exercised by the Holder hereof at
any time or from time to time during the Exercise Period by delivery of the
subscription form annexed hereto (duly executed by the Holder) to the Company
and by making payment, in cash or by certified or official bank check payable to
the order of the Company, in the amount obtained by multiplying (i) the number
of shares of Common Stock designated by the Holder in the subscription form by
(ii) the Purchase Price. If at the request of the Company the subscription form
is delivered to the Company's transfer agent for the Common Stock, the Holder
shall provide a copy of the subscription form to the Company at the time of
exercise and the Company will confirm the exercise instructions given therein by
notice to the Company's transfer agent within one Trading Day after receiving
such subscription form. Upon each exercise of this Warrant, whether by cash or
cashless exercise, the Holder shall not be required to surrender this Warrant to
the Company unless the Holder has no further rights to purchase shares of Common
Stock hereunder. The Holder and the Company shall maintain records showing the
number of shares purchased in connection with each exercise of this Warrant and
the dates of such exercises or shall use such other method, satisfactory to the
Holder and the Company, so as to not require physical surrender of this Warrant
upon each such exercise.

                  (a) CASHLESS EXERCISE. Subject to the limitations on exercises
in Sections 1.2 and 1.4(a), during the Exercise Period and at any time after the
earlier to occur of the SEC Effective Date (as defined in the Registration
Rights Agreement) and the date the initial registration statement filed pursuant
to the Registration Rights Agreement is declared effective by the Commission,
when a registration statement covering the resale of the Common Stock issuable

                                       9
<PAGE>

hereunder and naming the Holder as a selling stockholder thereunder is not then
effective, the Holder may surrender this Warrant to the Company together with a
notice of cashless exercise, in which event the Company shall issue to the
Holder the number of shares of Common Stock determined as follows:

                           X = Y [(A-B)/A]

                  where:

                           X = the number of shares of Common Stock to be issued
                  to the Holder.

                           Y = the number of shares of Common Stock with respect
                  to which this Warrant is being exercised.

                           A = the average of the closing sale prices of the
                  Common Stock for the five (5) trading days immediately prior
                  to (but not including) the date of exercise.

                           B = the Purchase Price.

For purposes of Rule 144 promulgated under the Securities Act, it is intended,
understood and acknowledged that the shares of Common Stock issued in a cashless
exercise transaction shall be deemed to have been acquired by the Holder, and
the holding period for such shares shall be deemed to have been commenced, on
the issue date of this Warrant.

                  (b) In lieu of delivering physical certificates
representing the shares of Common Stock issuable upon exercise of this
Warrant, provided the Company's transfer agent is participating in the
Depository Trust Company ("DTC") Fast Automated Securities Transfer ("FAST")
program, upon request of the Holder, the Company shall use its best efforts
to cause its transfer agent to electronically transmit the shares of Common
Stock issuable upon exercise to the Holder, by crediting the account of the
Holder's prime broker with DTC through its Deposit Withdrawal Agent
Commission ("DWAC") system. The time periods for delivery described above
shall apply to the electronic transmittals through the DWAC system. The
Company agrees to coordinate with DTC to accomplish this objective.

                  1.2 CERTAIN EXERCISE RESTRICTIONS.

                  (b) Notwithstanding anything to the contrary contained herein,
the number of shares of Common Stock that may be acquired by the Holder upon
exercise pursuant to the terms hereof shall not exceed a number that, when added
to the total number of shares of Common Stock deemed beneficially owned by such
Holder (other than by virtue of the ownership of securities or rights to acquire
securities that have limitations on the Holder's right to convert, exercise or
purchase similar to the limitation set forth herein), together with all shares
of Common Stock deemed beneficially owned (other than by virtue of the ownership
of securities or rights to acquire securities that have limitations on the
Holder's right to convert, exercise or purchase similar to the limitation set
forth herein) by the Holder's "Affiliates" (as defined in Rule 144 of the
Securities Act) ("Aggregation Parties") that would be aggregated for purposes of

                                       10
<PAGE>

determining whether a group under Section 13(d) of the Securities Exchange Act
of 1934, as amended, exists, would exceed 9.99% of the total issued and
outstanding shares of Common Stock (the "Restricted Ownership Percentage"). Each
Holder shall have the right (w) at any time and from time to time to reduce its
Restricted Ownership Percentage immediately upon notice to the Company and (x)
(subject to waiver) at any time and from time to time, to increase its
Restricted Ownership percentage immediately in the event of the announcement as
pending or planned, of a merger or consolidation of the Company, a sale of all
or substantially all of the assets of the Company, or the acquisition by any
third party (and/or such party's Aggregation Parties) of at least 50% of the
Company's outstanding Common Stock.

                  (c) The Holder covenants at all times on each day (each such
day being referred to as a "Covenant Day") as follows: during the balance of
such Covenant Day and the succeeding sixty-one (61) days (the balance of such
Covenant Day and the succeeding 61 days being referred to as the "Covenant
Period") such Holder will not acquire shares of Common Stock pursuant to any
right (including exercise of this Warrant) existing at the commencement of the
Covenant Period to the extent the number of shares so acquired by such Holder
and its Aggregation Parties (ignoring all dispositions) would exceed:

                  (x)      the Restricted Ownership Percentage of the total
                           number of shares of Common Stock outstanding at the
                           commencement of the Covenant Period,

                  MINUS

                  (y)      the number of shares of Common Stock owned by such
                           Holder and its Aggregation Parties at the
                           commencement of the Covenant Period.

                  A new and independent covenant will be deemed to be given by
the Holder as of each moment of each Covenant Day. No covenant will terminate,
diminish or modify any other covenant. The Holder agrees to comply with each
such covenant.

                  The Company's obligation to issue shares of Common Stock which
would exceed such limits shall be suspended to the extent necessary until such
time, if any, as shares of Common Stock may be issued in compliance with such
restrictions.

                                       11
<PAGE>

                  1.3 DETERMINATION OF SPECIFIED NUMBER. (a) On each Adjustment
Date, the number of Adjustment Shares shall be computed as follows:

         IF CP(less than or equal to symbol)ICP, and

                  IF CP(less than symbol) $2.27 and

                           IF CP (greater than or equal to symbol) MPP, then

                                    CS =    PPSH x 1.015, and

                                    BSH = CS - FSH, and

                                            if the Company elects to pay Holder
                                            B$ = BSH x CP,

                                                     AS = CS - BSH - PPSH

                                            or else  AS = CS - PPSH

                           but IF CP(less than symbol)MPP, then

                                    CS = (MPP x PPSH x (1.015)/CP

                                    BSH = CS - FSH, and

                                            if the Company elects to pay Holder
                                            B$ = BSH x CP,

                                    AS = CS - BSH - PPSH

                                            or else AS = CS -PPSH.

                  IF CP(less than symbol)ICP and IF CP(greater than or equal
                  to symbol) $2.27 and

                           IF CP (greater than or equal to symbol) MPP, then

                           AS = PPSH x .015

                                    or else AS = [(MPP x PPSH x 1.015)/CP] -
                                    PPSH

         IF CP(greater than symbol)ICP, then AS = 0

                                       12
<PAGE>

                  where:

                  AS       =        Adjustment Shares

                  CS       =        Initially calculated Adjustment Shares

                  I$       =        $2,000,000

                  ICP      =        $4.3692

                  BSH      =        Buyout Shares: The number of shares for
                                    which the Company may, in lieu of having the
                                    Specified Number increase by the applicable
                                    number of Adjustment Shares, elect to pay
                                    cash to the Holder in the amount of the
                                    Buyout.

                  FSH      =        Floor Shares (the number of shares that
                                    are not subject to the Company's election to
                                    buyout). The initial value of FSH shall be
                                    set to FSH = 881,168. FSH shall be
                                    recalculated at each Adjustment Date by
                                    multiplying the value of FSH as of the
                                    immediately preceding Adjustment Date by (1
                                    - (SHX/PPSH))

                  B$       =        Buyout Amount.

                  SHX      =        the number of Warrant shares exercised
                                    during the current Adjustment Period.

                  CP       =        the Average Market Price as of the
                                    then-current Adjustment Date.

                  PPSH     =        the number of Common Shares Held as of the
                                    immediately preceding Adjustment Date.

                  MPP      =        the lesser of ICP or the lowest Average
                                    Market Price as of any prior Adjustment Date
                                    (or ICP on the first Adjustment Date).

                  As indicated above, if as of any Adjustment Date the Average
Market Price is below $2.27 (as such number shall be appropriately adjusted for
any stock splits, recapitalizations or similar events), the Company may, in lieu
of having the increase in the Specified Number include the number of Buyout
Shares, elect to pay cash to the Holder in an amount equal to the Buyout Amount
(B$). Such election must be made by written notice to the holders within five
(5) business days after the applicable Adjustment Date and the Company must make
payment therefor in cash (i) within sixty (60) days after the first Adjustment
Date, if applicable and (ii) within five (5) business days after any subsequent
applicable Adjustment Date.

                                       13
<PAGE>

                  (b) Prior to the First Adjustment Date, the Specified Number
shall equal zero. For each Adjustment Date on which the number of Adjustment
Shares determined in accordance with Section 1.3(a) is a positive number,

                  (1) on the First Adjustment Date, the Specified Number shall
         equal the number of Adjustment Shares; and

                  (2) on each subsequent Adjustment Date, the Specified Number
         shall equal (x) the Specified Number determined on the immediately
         preceding Adjustment Date plus (y) the number of Adjustment Shares
         determined on the current Adjustment Date less (z) the number of shares
         of Common Stock for which this Warrant was exercised during the most
         recently completed Quarterly Period.

                  (c) The number of Adjustment Shares may not be a negative
number. For each Adjustment Date on which the number of Adjustment Shares
determined in accordance with Section 1.2(a) is zero or would otherwise be a
negative number, the Holder shall not be obligated to transfer any shares of
Common Stock to the Company.

                  (d) On each Adjustment Date or within three Trading Days
thereafter, the Holder shall give an Adjustment Notice in the form attached
hereto to the Company accompanied by the spreadsheet referred to Section 1.3(e)
used to calculate the Adjustment Shares. If the Holder fails to give an
Adjustment Notice within three Trading Days after any Adjustment Date, the
Company may notify the Holder of such failure and, if the Holder does not
deliver such Adjustment Notice within three Trading Days after such notice of
failure is given to the Holder, the Company shall give such Adjustment Notice to
the Holder. Absent manifest error, the Adjustment Notice and such spreadsheet
shall be binding on the Company and the Holder for purposes of making the
determinations required by this Section 1.3. The Company and the Holder shall
use their best efforts to promptly correct any error in any Adjustment Notice.

                  (e) A spreadsheet illustrating the application of the forgoing
is annexed hereto and made a part hereof; such spreadsheet shall be used in
calculating Adjustment Shares pursuant to this Section 1.3.

                  1.4 MAXIMUM SHARE LIMITATION; REPURCHASE RIGHTS. Provided that
the Common Stock is listed for trading on Nasdaq or another market having the
Shareholder Approval Rule or an equivalent rule, and provided that Shareholder
Approval or the equivalent has not been obtained, this Warrant may not be
exercised to purchase shares of Common Stock to the extent, and only to the
extent, such exercise would cause the Total Common Shares of the Holder plus, to
the extent aggregation with the Total Common Shares is required under the
Shareholder Approval Rule, other shares of Common Stock acquired under the
subscription agreements, one dated July 31, 2000 and one dated August 30, 2000,
each between Millennium and the Company, and the warrants issued in connection
therewith to exceed the Share Limit. If such conditions obtain and if an
exercise in full of this Warrant and/or the Callable Warrant would, but for the
preceding sentence and the other limitations contained in Sections 1.1 and 1.2
above, cause the Total Common Shares to exceed the Share Limit:

                                       14
<PAGE>

                  (a) If (i) (at the time of the Company's exercise of its right
in this sentence) the Company shall be in compliance in all material respects
with its obligations to the Holder (including, without limitation, its
obligations under this Warrant, the Callable Warrant, the Subscription Agreement
and the Registration Rights Agreement), (ii) on the date the Repurchase Notice
is given and at all times until the Repurchase Date, the Registration Statement
is effective and available for use by the Holder for the resale of all of its
Shares of Common Stock previously issued or issuable and (iii) on the date the
Repurchase Notice is given and on the Repurchase Date, the Company has available
unrestricted Cash and Cash Equivalent Balances not less than the aggregate
amount to be paid to repurchase shares of Common Stock pursuant to Section 1.4
of this Warrant and the Other Class A Warrants, then the Company shall have the
right to repurchase the shares of Common Stock issuable pursuant to the Warrant
and/or the Callable Warrant held by the Holder in accordance with Section
1.4(b).

                  (b) To exercise its repurchase right, the Company shall give a
Repurchase Notice, not more frequently than once in any period of 180
consecutive days, on the Trading Day immediately following an Adjustment Date.
If the Repurchase Notice is timely given, the Company shall be obligated to
repurchase such portion of the shares issuable pursuant to this Warrant and/or
the Callable Warrant (in proportions designated by the Holder) which exceed the
Share Limit on a Repurchase Date which is not less than 20 Trading Days or more
than 30 Trading Days after the date of the Repurchase Notice, if this Warrant
and/or the Callable Warrant is to be repurchased pursuant to this Section 1.4,
the Company shall repurchase such Warrants as if such Warrants had been
exercised, to the extent of the portion of the Warrants being repurchased, on
the Repurchase Date and the shares of Common Stock issuable upon such exercise
were held directly by the Holder and were being repurchased. On the Repurchase
Date, the Company shall make payment to the Holder of the applicable Repurchase
Price multiplied by the number of shares of Common Stock to be repurchased in
immediately available funds to such account as specified by the Holder in
writing to the Company at least one Trading Day prior to the Repurchase Date,
provided that if such payment is not so made on the Repurchase Date, the Company
shall be obligated to repurchase such number of shares at a purchase price equal
to the Holder Repurchase Price per share. Notwithstanding anything to the
contrary in the foregoing provisions of this Section 1.4, prior to the
Repurchase Date, or such later date on which the Repurchase Price is paid, the
Holder shall be free to exercise this Warrant as long as such exercise does not
violate the first sentence of this Section 1.4.

                  (c) If the Company does not timely give a Repurchase Notice
pursuant to subsection (b) above, the Company shall have the option by written
notice to the Holder, and the Holder shall have the right to require the Company
by written notice, to seek the Shareholder Approval applicable to an issuance of
shares in excess of the Share Limit ("Excess Shares") as soon as possible, but
in any event, not later than the 75th day after such election or the Holder's
demand, and if the Company shall have failed to receive Shareholder Approval
within five (5) Business Days of such 75th day, the Company shall, on such fifth
Business Day, pay cash to such Holder in an amount equal to the Holder
Repurchase Price multiplied by the number of Excess Shares. If the Company fails
to pay the Holder Repurchase Price in full pursuant to this Section 1.4 within
seven days after the date payable, the Company will pay interest thereon at a
rate of 18% per annum or such lesser maximum amount that is permitted to be paid
by applicable law, to the Holder, accruing daily from such fifth Business Day
until such amount, plus all such interest thereon, is paid in full.

                                       15
<PAGE>

                  2. DELIVERY OF STOCK CERTIFICATES, ETC., ON EXERCISE. (a) As
soon as practicable after the exercise of this Warrant, and in any event within
three Trading Days thereafter, the Company at its expense (including the payment
by it of any applicable issue or stamp taxes) will cause to be issued in the
name of and delivered to the Holder hereof, or as the Holder (upon payment by
the Holder of any applicable transfer taxes) may direct, a certificate or
certificates for the number of fully paid and nonassessable shares of Common
Stock (or Other Securities) to which the Holder shall be entitled on such
exercise, in such denominations as may be requested by the Holder, plus, in lieu
of any fractional share to which the Holder would otherwise be entitled, cash
equal to such fraction multiplied by the then current fair market value (as
reasonably determined by the Company) of one full share, together with any other
stock or other securities and property (including cash, where applicable) to
which the Holder is entitled upon such exercise pursuant to Section 1 or
otherwise. Upon exercise of this Warrant as provided herein, the Company's
obligation to issue and deliver the certificates for Common Stock shall be
absolute and unconditional, irrespective of the absence of any action by the
Holder to enforce the same, any waiver or consent with respect to any provision
thereof, the recovery of any judgment against any person or any action to
enforce the same, any failure or delay in the enforcement of any other
obligation of the Company to the Holder, or any setoff, counterclaim,
recoupment, limitation or termination, or any breach or alleged breach by the
Holder or any other person of any obligation to the Company, and irrespective of
any other circumstance which might otherwise limit such obligation of the
Company to the Holder in connection with such exercise. If the Company fails to
issue and deliver the certificates for the Common Stock to the Holder pursuant
to the first sentence of this paragraph as and when required to do so, in
addition to any other liabilities the Company may have hereunder and under
applicable law, the Company shall pay or reimburse the Holder on demand for all
out-of-pocket expenses including, without limitation, reasonable fees and
expenses of legal counsel incurred by the Holder as a result of such failure.

                  (b) If the Company fails to deliver to the Holder a
certificate or certificates representing the shares of Common Stock pursuant to
Section 2(a) by the third Trading Day after each date of exercise of this
Warrant, the Company shall pay to the Holder, in cash, as liquidated damages and
not as a penalty, $5,000 for each day after such third Trading Day until such
certificates are delivered (for clarification purposes, such liquidated damages
are independent of other Class A Warrants and relate only to this Class A
Warrant). The payment and acceptance of any cash penalty shall not preclude the
Holder from proceeding under the next paragraph 2(c); provided that any amounts
actually paid to the Holder under this paragraph 2(b) herein shall be deducted
(but not below zero) from the amount otherwise recoverable under paragraph 2(c)
below.

                  (c) In addition to any other rights available to the Holder,
but subject to paragraph 2(b) above, if the Company fails to deliver to the
Holder a certificate or certificates representing shares of Common Stock
pursuant to Section 2(a) by the third Trading Day after the date of exercise of
this Warrant, and if after such third Trading Day the Holder purchases (in an
open market transaction or otherwise) shares of Common Stock to deliver in
satisfaction of a sale by the Holder of the shares of Common Stock which the
Holder anticipated receiving upon such exercise (a "Buy-In"), then the Company
shall pay (1) in cash to the Holder the amount by which (x) the Holder's total
purchase price (including brokerage commissions, if any) for the shares of
Common Stock so purchased exceeds (y) the amount obtained by multiplying (A) the
number of

                                       16
<PAGE>

shares of Common Stock that the Company was required to deliver pursuant to
Section 2(a) to deliver to the Holder in connection with the exercise at issue
by (B) the Market Price at the time of the sale giving rise to such purchase
obligation and (2) deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise
and delivery obligations under Section 2(a). For example, if the Holder
purchases Common Stock having a total purchase price of $11,000 to cover a
Buy-In with respect to an attempted exercise of shares of Common Stock with a
Market Price on the date of exercise totaled $10,000, under clause (A) of the
immediately preceding sentence the Company shall be required to pay the Holder
$1,000. The Holder shall provide the Company written notice and appropriate
documentation indicating the amounts payable to the Holder in respect of the
Buy-In.

                  3. ADJUSTMENT FOR DIVIDENDS IN OTHER STOCK, PROPERTY, ETC.;
RECLASSIFICATION, ETC. In case at any time or from time to time after the
Issuance Date, all the holders of Common Stock (or Other Securities) shall have
received, or (on or after the record date fixed for the determination of
stockholders eligible to receive) shall have become entitled to receive, without
payment therefor,

                  (b) other or additional stock or other securities or property
(other than cash) by way of dividend, or

                  (c) any cash (excluding cash dividends payable solely out of
earnings or earned surplus of the Company), or

                  (d) other or additional stock or other securities or property
(including cash) by way of spin-off, split-up, reclassification,
recapitalization, combination of shares or similar corporate rearrangement,

other than additional shares of Common Stock (or Other Securities) issued as a
stock dividend or in a stock-split (adjustments in respect of which are provided
for in Section 5), then and in each such case the Holder shall be entitled to
receive, at the same time as holders of Common Stock, the amount of stock and
other securities and property (including cash in the cases referred to in
subdivisions (b) and (c) of this Section 3) which the Holder would have received
if on the date thereof the Holder had been the holder of record of the Specified
Number, after giving effect to all adjustments called for during such period by
Section 4. Notwithstanding anything in this Section 3 to the contrary, no
adjustments pursuant to this Section 3 shall actually be made until the
cumulative effect of the adjustments called for by this Section 3 since the date
of the last adjustment actually made would change the amount of stock or other
securities and property which the Holder would hold by more than 1%.

                  4. EXERCISE UPON REORGANIZATION, CONSOLIDATION, MERGER, ETC.
In case of any (1) merger or consolidation of the Company with or into another
person, or (2) sale by the Company of more than one-half of the assets of the
Company (on a book value basis) in one or a series of related transactions, or
(3) tender or other offer or exchange (whether by the Company or another person)
pursuant to which holders of Common Stock are permitted to tender or exchange
their shares for other securities, stock, cash or property of the Company or
another Person; then the Holder shall have the right thereafter to (A) exercise
this Warrant for the shares of stock and other securities, cash and property
receivable upon or deemed to be held by holders

                                       17
<PAGE>

of Common Stock following such merger, consolidation or sale, and the Holder
shall be entitled upon such event or series of related events to receive such
amount of securities, cash and property as the Common Stock for which this
Warrant could have been exercised immediately prior to such merger,
consolidation or sale would have been entitled, (B) in the case of a merger or
consolidation, (x) require the surviving entity to issue to the Holder a warrant
entitling the Holder to acquire shares of such entity's common stock, which
warrant shall have terms identical (including with respect to exercise) to the
terms of this Warrant and shall be entitled to all of the rights and privileges
set forth herein and the agreements pursuant to which this Warrant was issued
(including, without limitation, as such rights relate to the acquisition,
transferability, registration and listing of such shares of stock other
securities issuable upon exercise thereof), or (C) in the event of an exchange
or tender offer or other transaction contemplated by clause (3) of this Section,
tender or exchange this Warrant for such securities, stock, cash and other
property receivable upon or deemed to be held by holders of Common Stock that
have tendered or exchanged their shares of Common Stock following such tender or
exchange, and the Holder shall be entitled upon such exchange or tender to
receive such amount of securities, cash and property as the shares of Common
Stock for which this Warrant could have been exercised immediately prior to such
tender or exchange would have been entitled as would have been issued. In the
case of clause (B), the exercise price applicable for the newly issued warrant
shall be based upon the amount of securities, cash and property that each share
of Common Stock would receive in such transaction and the Purchase Price
immediately prior to the effectiveness or closing date for such transaction. The
terms of any such merger, sale, consolidation, tender or exchange shall include
such terms so as continue to give the Holder the right to receive the
securities, cash and property set forth in this Section upon any conversion or
redemption following such event. This provision shall similarly apply to
successive such events.

                  5. ADJUSTMENT FOR EXTRAORDINARY EVENTS. In the event that
after the Issuance Date the Company shall (i) issue additional shares of Common
Stock as a dividend or other distribution on outstanding Common Stock, (ii)
subdivide or reclassify its outstanding share of Common Stock, or (iii) combine
its outstanding share of Common Stock into a smaller number of shares of Common
Stock, then, in each event, the Specified Number shall, simultaneously with the
happening of such event, be adjusted by multiplying the Specified Number in
effect immediately prior to such event by a fraction, the numerator of which
shall be the number of shares of Common Stock outstanding immediately after such
event and the denominator of which shall be the number of shares of Common Stock
outstanding immediately prior to such event, and the product so obtained shall
thereafter be the Specified Number then in effect. The Specified Number, as so
adjusted, shall be readjusted in the same manner upon the happening of any
successive event or events described in this Section 5.

                  6. FURTHER ASSURANCES. Subject to the terms hereof, the
Company will take all action that may be necessary or appropriate in order that
the Company may validly and legally issue fully paid and nonassessable shares of
stock, free from all taxes, liens and charges with respect to the issue thereof,
on the exercise of all or any portion of this Warrant from time to time
outstanding.

                  7. NOTICES OF RECORD DATE, ETC. In the event of

                                       18
<PAGE>

                  (a) any taking by the Company of a record of the holders of
any class of securities for the purpose of determining the holders thereof who
are entitled to receive any dividend on, or any right to subscribe for, purchase
or otherwise acquire any shares of stock of any class or any other securities or
property, or to receive any other right, or

                  (b) any capital reorganization of the Company, any
reclassification or recapitalization of the capital stock of the Company or any
transfer of all or substantially all of the assets of the Company to or
consolidation or merger of the Company with or into any other person (other than
a wholly-owned subsidiary of the Company), or

                  (c) any voluntary or involuntary dissolution, liquidation or
winding-up of the Company,

then and in each such event the Company will mail or cause to be mailed to the
Holder, at least ten days prior to such record date, a notice specifying (i) the
date on which any such record is to be taken for the purpose of such dividend,
distribution or right, and stating the amount and character of such dividend,
distribution or right, (ii) the date on which any such reorganization,
reclassification, recapitalization, transfer, consolidation, merger,
dissolution, liquidation or winding-up is to take place, and the time, if any is
to be fixed, as of which the holders of record of Common Stock (or Other
Securities) shall be entitled to exchange their shares of Common Stock (or Other
Securities) for securities or other property deliverable on such reorganization,
reclassification, recapitalization, transfer, consolidation, merger,
dissolution, liquidation or winding-up, and (iii) the amount and character of
any stock or other securities, or rights or options with respect thereto,
proposed to be issued or granted, the date of such proposed issue or grant and
the persons or class of persons to whom such proposed issue or grant is to be
offered or made. Such notice shall also state that the action in question or the
record date is subject to the effectiveness of a registration statement under
the 1933 Act, or a favorable vote of stockholders, if either is required. Such
notice shall be mailed at least ten days prior to the date specified in such
notice on which any such action is to be taken or the record date, whichever is
earlier.

                  8. RESERVATION OF STOCK, ETC., ISSUABLE ON EXERCISE OF
WARRANTS. The Company will at all times reserve and keep available out of its
authorized but unissued shares of capital stock, solely for issuance and
delivery on the exercise of this Warrant, a sufficient number of shares of
Common Stock (or Other Securities) to effect the full exercise of this Warrant
and the exercise, conversion or exchange of any other warrant or security of the
Company exercisable for, convertible into, exchangeable for or otherwise
entitling the holder to acquire shares of Common Stock (or Other Securities),
and if at any time the number of authorized but unissued shares of Common Stock
(or Other Securities) shall not be sufficient to effect such exercise,
conversion or exchange, the Company shall take such action as may be necessary
to increase its authorized but unissued shares of Common Stock (or Other
Securities) to such number as shall be sufficient for such purposes.

                  9. TRANSFER OF WARRANT. This Warrant shall inure to the
benefit of the successors to and assigns of the Holder. This Warrant and all
rights hereunder, in whole or in part, are registrable at the office or agency
of the Company referred to below by the Holder hereof in person or by his duly
authorized attorney, upon surrender of this Warrant properly endorsed.

                                       19
<PAGE>

                  10. REGISTER OF WARRANTS. The Company shall maintain, at the
principal office of the Company (or such other office as it may designate by
notice to the Holder hereof), a register in which the Company shall record the
name and address of the person in whose name this Warrant has been issued, as
well as the name and address of each successor and prior owner of such Warrant.
The Company shall be entitled to treat the person in whose name this Warrant is
so registered as the sole and absolute owner of this Warrant for all purposes.

                  11. EXCHANGE OF WARRANT. This Warrant is exchangeable, upon
the surrender hereof by the Holder hereof at the office or agency of the Company
referred to in Section 10, for one or more new Warrants of like tenor
representing in the aggregate the right to subscribe for and purchase the number
of shares of Common Stock which may be subscribed for and purchased hereunder,
each of such new Warrants to represent the right to subscribe for and purchase
such number of shares as shall be designated by said Holder hereof at the time
of such surrender.

                  12. REPLACEMENT OF WARRANT. On receipt of evidence reasonably
satisfactory to the Company of the loss, theft, destruction or mutilation of
this Warrant and, in the case of any such loss, theft or destruction of this
Warrant, on delivery of an indemnity agreement or security reasonably
satisfactory in form and amount to the Company or, in the case of any such
mutilation, on surrender and cancellation of this Warrant, the Company at its
expense will execute and deliver, in lieu thereof, a new Warrant of like tenor.

                  13. WARRANT AGENT. The Company may, by written notice to the
Holder, appoint the transfer agent and registrar for the Common Stock as the
Company's agent for the purpose of issuing shares of Common Stock (or Other
Securities) on the exercise of this Warrant pursuant to Section 1, and the
Company may, by notice to the Holder, appoint an agent having an office in the
United States of America for the purpose of exchanging this Warrant pursuant to
Section 11 and replacing this Warrant pursuant to Section 12, or either of the
foregoing, and thereafter any such exchange or replacement, as the case may be,
shall be made at such office by such agent.

                  14. REMEDIES. The Company stipulates that the remedies at law
of the Holder in the event of any default or threatened default by the Company
in the performance of or compliance with any of the terms of this Warrant are
not and will not be adequate, and that such terms may be specifically enforced
by a decree for the specific performance of any agreement contained herein or by
an injunction against a violation of any of the terms hereof or otherwise.

                  15. NO RIGHTS OR LIABILITIES AS A STOCKHOLDER. This Warrant
shall not entitle the Holder hereof to any voting rights or other rights as a
stockholder of the Company. No provision of this Warrant, in the absence of
affirmative action by the Holder hereof to purchase Common Stock, and no mere
enumeration herein of the rights or privileges of the Holder hereof, shall give
rise to any liability of the Holder for the Purchase Price or as a stockholder
of the Company, whether such liability is asserted by the Company or by
creditors of the Company.

                  16. NOTICES, ETC. All notices and other communications from
the Company to the registered Holder or from the registered Holder to the
Company shall be delivered personally (which shall include telephone line
facsimile transmission with answer back confirmation) or by

                                       20
<PAGE>

courier and shall be effective upon receipt, addressed to each party at the
address or telephone line facsimile transmission number for each party set forth
in the Subscription Agreement or at such other address or telephone line
facsimile transmission number as a party shall have provided to the other party
in accordance with this provision.

                  17. TRANSFER RESTRICTIONS. By acceptance of this Warrant, the
Holder represents to the Company that this Warrant is being acquired for the
Holder's own account and for the purpose of investment and not with a view to,
or for sale in connection with, the distribution thereof, nor with any present
intention of distributing or selling this Warrant or the Common Stock issuable
upon exercise of this Warrant. The Holder acknowledges and agrees that this
Warrant and, except as otherwise provided in the Registration Rights Agreement,
the shares of Common Stock issuable upon exercise of this Warrant (if any) have
not been (and at the time of acquisition by the Holder, will not have been or
will not be), registered under the 1933 Act or under the securities laws of any
state, in reliance upon certain exemptive provisions of such statutes. The
Holder further recognizes and acknowledges that (a) because this Warrant and,
except as provided in the Registration Rights Agreement, the Common Stock
issuable upon exercise of this Warrant (if any) are unregistered, they may not
be eligible for resale, and may only be resold in the future pursuant to an
effective registration statement under the 1933 Act and any applicable state
securities laws, or pursuant to a valid exemption from such registration
requirements and (b) this Warrant and the Common Stock issuable upon the
exercise hereof are subject to the transfer restrictions and other terms,
conditions and obligations set forth in the Registration Rights Agreement and in
the Subscription Agreement. Unless the shares of Common Stock issuable upon
exercise of this Warrant have theretofore been registered for resale under the
1933 Act, the Company may require, as a condition to the issuance of Common
Stock upon the exercise of this Warrant a confirmation as of the date of
exercise of the Holder's representations pursuant to this Section 17.

                  18. LEGEND. Except to the extent required by the Subscription
Agreement, each certificate for shares issued upon exercise of this Warrant
shall be free of any restrictive legend.

                  19. ATTORNEYS' FEES. In any litigation, arbitration or court
proceeding between the Company and Holder relating hereto, the prevailing party
shall be entitled to attorneys' fees and expenses and all costs of proceedings
incurred in enforcing this Warrant; provided that the prevailing party may only
recover attorney's fees and expenses aggregating up to 35% of the amount sought
in good faith to be recovered.

                  20. AMENDMENT; WAIVER. This Warrant and any terms hereof may
be changed, waived, discharged or terminated only by an instrument in writing
signed by the party against which enforcement of such change, waiver, discharge
or termination is sought.

                  21. MISCELLANEOUS. The corporate laws of the State of Delaware
shall govern all issues concerning the relative rights of the Company and its
stockholders. All other questions concerning the construction, validity,
enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New
York, without regard to the principles of conflicts of law thereof. The Company
and the Holder hereby irrevocably submit to the exclusive jurisdiction of the
state and federal courts sitting in

                                       21
<PAGE>

the City of New York, borough of Manhattan, for the adjudication of any dispute
hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in
any suit, action or proceeding, any claim that it is not personally subject to
the jurisdiction of any such court, or that such suit, action or proceeding is
improper. Each of the Company and the Holder hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action
or proceeding by certified mail, return receipt requested, and agrees that such
service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right
to serve process in any manner permitted by law.

                                       22
<PAGE>

                  IN WITNESS WHEREOF, the Company has caused this Warrant to be
executed on its behalf by one of its officers thereunto duly authorized.

Dated:  June 21, 2001               STEMCELLS, INC.

                                    By:  /s/ Martin M. McGlynn
                                         ---------------------------------------
                                    Name: Martin M. McGlynn
                                         ---------------------------------------
                                    Title:  President, Chief Executive Officer
                                            ------------------------------------

                                       23
<PAGE>

                              FORM OF SUBSCRIPTION

                                 STEMCELLS, INC.

                   (To be signed only on exercise of Warrant)

TO:      STEMCELLS, INC.
         3155 Porter Drive
         Palo Alto, California 94304

         Attention:  Chief Financial Officer

                  1. The undersigned Holder of the attached original, executed
Warrant hereby elects to exercise its purchase right under such Warrant with
respect to ______________ shares of Common Stock, as defined in the Warrant, of
StemCells, Inc., a Delaware corporation (the "Company").

                  2. The undersigned Holder elects to pay the aggregate purchase
price for such shares of Common Stock (the "Exercise Shares") (i) by lawful
money of the United States or the enclosed certified or official bank check
payable in United States dollars to the order of the Company in the amount of
$___________, or (ii) by wire transfer of United States funds to the account of
the Company in the amount of $____________, which transfer has been made before
or simultaneously with the delivery of this Form of Subscription pursuant to the
instructions of the Company.

                  3. The undersigned Holder represents and warrants that it is
an accredited investor as defined under Rule 501(a) promulgated under the
Securities Act of 1933, as amended.

                  4. Please issue a stock certificate or certificates
representing the appropriate number of shares of Common Stock in the name of the
undersigned or in such other name as is specified below:

                  Name:
                         ---------------------------------------------

                  Address:
                            ------------------------------------------

                            ------------------------------------------

                  5. The undersigned Holder hereby represents to the Company
that the exercise of the Warrant elected hereby does not violate Section 1.2 of
the Warrant.

                                       24
<PAGE>

Dated: ____________ ___, ____        HOLDER:

                                     -------------------------------------------

                                     By:
                                        ----------------------------------------
                                        (Signature must conform to name of
                                        Holder as specified on the face of the
                                        Warrant)
                                     Name:

                                     Title:

                                     Address:
                                             -----------------------------------

                                     -------------------------------------------

                                       25
<PAGE>

                                ADJUSTMENT NOTICE

TO:      STEMCELLS, INC.
         3155 Porter Drive
         Palo Alto, California 94304

         Attention:  Chief Financial Officer

         Facsimile No:  650-475-3101

                  This Adjustment Notice is given pursuant to the terms of the
Common Stock Purchase Warrant, Class A, dated June 21, 2001, issued by
STEMCELLS, INC., a Delaware corporation (the "Warrant"). Capitalized terms used
herein and not otherwise defined herein have the respective meanings provided in
the Warrant. Attached hereto is a copy of the spreadsheet used pursuant to
Section 1.3(e) of the Warrant to prepare this notice. The undersigned Holder
hereby notifies the Company as follows:

                           (1)      Adjustment Date:
                                                     ---------------------------

                           (2)      Computation of number of Adjustment Shares
                                    ("AS") pursuant to Section 1.3(a):

                           (a)      Common Shares Held as of prior Adjustment
                                    Date:
                                          -------------

                           (b)      To determine the Average Market Price, the
                                    ten lowest Market Prices during the 30
                                    Trading Days during the Measurement Period
                                    were as follows:

                           DATE     PRICE ($)           DATE       PRICE ($)
                           ----     ---------           ----       ---------

                           (c)      Lowest Average Market Price as of any
                                    previous Adjustment Date:
                                    $_________.

                           (d)      Adjustment Shares:  ______________

                           (3)      Specified Number on preceding Adjustment
                                    Date:  __________

                           (4)      Shares issued upon exercises during last
                                    Quarterly Period:  _____

                           (5)      Specified Number on Adjustment Date:
                                    _______________

                                       26
<PAGE>

                                NAME OF HOLDER:

Date:
       ---------------------    ------------------------------------------------

                                By:
                                     -------------------------------------------
                                         Name:
                                         Title:

                                       27

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00027-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00027-of-00352.parquet"}]]